Final results of a phase I/II trial of palbociclib and CPX-351 in patients with Acute Myeloid Leukemia

Authors
Category Primary study
Conference67th American Society of Hematology Annual Meeting, ASH 2025
Year 2025
This article has no abstract
Epistemonikos ID: 0f1c014c019dff676a1077eadfa02bbeb52415d9
First added on: Jun 15, 2026